Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Jean-Paul Clozel
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Actelion in $360M settlement - San Francisco Business Times
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
Idorsia, a small company with a big portfolio says Martine Clozel
Actelion Could Boost Takeover Price for Johnson & Johnson
J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg
Was plant das Ehepaar Clozel? | NZZ
Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine
Jean-Paul Clozel
Jean-Paul Clozel | EY - Global
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Jean-Paul Clozel, CEO Actelion - YouTube
Der Manager des Jahres heisst Jean-Paul Clozel | Finanz und Wirtschaft
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Actelion: Die Knackpunkte eines Deals mit Johnson & Johnson | Tages-Anzeiger
Startup Guide on Twitter: "Jean-Paul and Martine Clozel are experienced founders and leading figures in the Basel Area. After Actelion, the first company they cofounded, was acquired by Johnson & Johnson, they
Biotech: Jean-Paul Clozel kämpft bei Idorsia mit Gegenwind
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) e Actelion CEO e fondatore Jean-Paul Clozel partecipano a una conferenza stampa presso la sede centrale di Actelion ad Allschwil, Svizzera, 26
Jean-Paul Clozel – mit Herzblut für Actelion - Rendez-vous - SRF
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Molecular Millionaire: Jean-Paul Clozel of Actelion
Actelion never made offer for ZS Pharma: CEO
